Logo image of MACK

MERRIMACK PHARMACEUTICALS IN (MACK) Stock Analyst Ratings

USA - NASDAQ:MACK - US5903282094 - Common Stock

15.13 USD
0 (0%)
Last: 5/17/2024, 8:11:51 PM
15.16 USD
+0.03 (+0.2%)
After Hours: 5/17/2024, 8:11:51 PM
Buy % Consensus

45

ChartMill assigns a Buy % Consensus number of 45% to MACK. The Buy consensus is the weighted average rating of the current analysts ratings.

MACK was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about MACK.
In the previous month the buy percentage consensus was at a similar level.
MACK was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

MACK Historical Analyst RatingsMACK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -35 -32 -29 -26 -23 -20 -17 -14 -11 -8 -5 -2 2 4 6 8 10

Related screens

MACK Current Analyst RatingMACK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

MERRIMACK PHARMACEUTICALS IN / MACK FAQ

What is the consensus rating for MACK stock?

The consensus rating for MERRIMACK PHARMACEUTICALS IN (MACK) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


Can you provide the analyst count for MERRIMACK PHARMACEUTICALS IN stock?

The number of analysts covering MERRIMACK PHARMACEUTICALS IN (MACK) is 8.